PROMIS NEUROSCIENCES INC has a total of 15 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AMORFIX LIFE SCIENCES LTD, DMNOMORE and ORBAN BIOTECH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Animal care | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Cashman Neil R | 9 |
#2 | Cashman Neil | 6 |
#3 | Ostermann Joachim Bernhard | 6 |
#4 | Chakrabartty Avijit | 6 |
#5 | Rakhit Rishi | 6 |
#6 | Uger Marni Diane | 3 |
#7 | Ciolfi Veronica | 3 |
#8 | Gibbs Ebrima | 2 |
#9 | Kaplan Johanne | 2 |
#10 | Silverman Judith Maxwell | 2 |
Publication | Filing date | Title |
---|---|---|
CA2927309A1 | Fasr antibodies for diagnostic and therapeutic use | |
US2015166668A1 | Antibodies and conjugates that target misfolded prion protein | |
AU2007219615A1 | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases | |
AU2004266324A1 | Epitope protection assay and method for detecting protein conformations |